Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays

Journal of Clinical Microbiology

Volumn 34, Issue 9, 1996, Pages 2312-2315

  Scott, Walter A ^a   Brambilla, Donald ^b   Siwak, Edward ^c   Beatty, Carolyn ^d   Bremer, James ^e   Coombs, Robert W ^f   Farzadegan, Homayoon ^g   Fiscus, Susan A ^h   Hammer, Scott M ⁱ   Hollinger, F Blaine ^c   Khan, Narayan ^j,m   Rasheed, Suraiya ^k   Reichelderfer, Patricia S ^l  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j Maryland Med Met Path   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^m Braton Biotech Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SUSPENSION; DIAGNOSTIC ACCURACY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; STANDARDIZATION; VIRUS CULTURE; VIRUS DETECTION; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 9444259812     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.9.2312-2315.1996     Document Type: Article

References (32)

1. Burke, D. S., A. K. Fowler, R. R. Redfield, S. Dilworth, C. N. Oster, and the Walter Reed Retroviral Research Group. 1990. Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture. J. Acquired Immune Defic. Syndr. 3:1159-1167.
2. Castro, B. A., C. D. Weiss, L. D. Wiviott, and J. A. Levy. 1988. Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. J. Clin. Microbiol. 26:2371-2376.
3. Coombs, R. W., A. C. Collier, J.-P. Allain, B. Nikora, M. Leuther, G. F. Gjerset, and L. Corey. 1989. Plasma viremia in human immunodeficiency virus infection. N. Engl. J. Med. 321:1626-1631.
4. Coombs, R. W., D. R. Henrard, W. F. Mehaffey, J. Gibson, E. Eggert, T. C. Quinn, and J. Phillips. 1993. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J. Clin. Microbiol. 31:1980-1986.
5. Dimitrov, D. H., J. L. Melnick, and F. B. Hollinger. 1990. Microculture assay for isolation of human immunodeficiency virus type 1 and for titration of infected peripheral blood mononuclear cells. J. Clin. Microbiol. 28:734-737.
6. Division of AIDS, National Institute of Allergy and Infectious Diseases. 1994. ACTG virology manual for HIV laboratories. Publication NIH-94-3828. National Institutes of Allergy and Infectious Diseases, Bethesda, Md.
7. D'Souza, M. P., G. Milman, J. A. Bradac, D. McPhee, C. V. Hanson, R. M. Hendry, and Collaborating Investigators. 1995. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies. AIDS 9:867-874.
8. Erice, A., K. J. Sannerud, V. L. Leske, D. Aeppli, and H. H. Balfour, Jr. 1992. Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes. J. Clin. Microbiol. 30:444-448.
9. Evans, L. A., T. M. McHugh, D. P. Stites, and J. A. Levy. 1987. Differential ability of human immunodeficiency virus isolates to productively infect human cells. J. Immunol. 138:3415-3418.
10. Fiscus, S. A., V. DeGruttola, P. Gupta, D. A. Katzenstein, W. A. Meyer III, M. L. LoFaro, M. Katzman, M. V. Ragni, P. S. Reichelderfer, and R. W. Coombs. 1995. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial. J. Infect. Dis. 171:305-311.
11. Folks, T., J. Kelly, S. Benn, A. Kinter, J. Justement, J. Gold, R. Redfield, K. W. Sell, and A. S. Fauci. 1986. Susceptibility of normal human lymphocytes Io infection with HTLV-III/LAV. J. Immunol. 136:4049-4053.
12. Gupta, P., A. Enrico, J. Armstrong, M. Doerr, M. Ho, and C. Rinaldo. 1990. A semiquantitative microassay for measurement of relative number of blood mononuclear cells infected with human immunodeficiency virus. AIDS Res. Hum. Retroviruses 6:1193-1196.
13. Hammer, S., C. Crumpacker, R. D'Aquila, B. Jackson, J. Lathey, D. Livnat, and P. Reichelderfer. 1993. Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J. Clin. Microbiol. 31:2557-2564.
14. Henrard, D. R., J. F. Phillips, L. R. Muenz, W. A. Blattner, D. Wiesner, M. E. Eyster, and J. J. Goedert. 1995. Natural history of HIV-1 cell-free viremia. JAMA 274:554-558.
15. Ho, D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in blood of infected persons. N. Engl. J. Med. 321: 1621-1625.
16. Hollinger, F. B., J. W. Bremer, L. E. Myers, J. W. M. Gold, and L. McQuay. 1992. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J. Clin. Microbiol. 30:1787-1794.
17. Hughes, M. Personal communication.
18. Jackson, J. B., R. W. Coombs, K. Sannerud, F. S. Rhame, and H. H. Balfour, Jr. 1988. Rapid and sensitive viral culture method for human immunodeficiency virus type 1. J. Clin. Microbiol. 26:1416-1418.
19. Jackson, J. B., S. Y. Kwok, J. J. Sninsky, J. S. Hopsicker, K. J. Sannerud, F. S. Rhame, K. Henry, M. Simpson, and H. H. Balfour, Jr. 1990. Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J. Clin. Microbiol. 28:16-19.
20. Katzenstein, D. A., M. Holodniy, D. M. Israelski, S. Sengupta, L. A. Mole, J. L. Bubp, and T. C. Merigan. 1992. Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment. J. Acquired Immune Defic. Syndr. 5:107-112.
21. Koyanagi, Y., S. Miles, R. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Y. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
22. Laird, N., and J. Ware. 1982. Random-effects models for longitudinal data. Biomedics 38:963-974.
23. Lathey, J. L., S. A. Fiscus, S. Rasheed, J. C. Kappes, B. P. Griffith, T. Elbeik, S. A. Spector, P. S. Reichelderfer and the Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group. 1994. Optimization of quantitative culture assay for human immunodeficiency virus from plasma. J. Clin. Microbiol. 32:3064-3067.
24. Miedema, F., and M. R. Klein. 1996. AIDS pathogenesis: a finite immune response to blame? Science 272:505-506.
25. Morrison, D. F. 1990. Multivariate statistical methods, 3rd ed., p. 1-495. McGraw-Hill Book Co., New York.
26. Myers, L. E., L. J. McQuay, and F. B. Hollinger. 1994. Dilution assay statistics. J. Clin. Microbiol. 32:732-739.
27. O'Brien, W. A., Y. Koyanagi, A. Namazie, J.-Q. Zhao, A. Diagne, K. Idler, J. A. Zack, and I. S. Y. Chen. 1990. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (London) 348:69-73.
28. Pan, L.-Z., A. Werner, and J. A. Levy. 1993. Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages. J. Clin. Microbiol. 31:283-288.
29. + T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann. Intern. Med. 113:438-443.
30. Spira, A. I., and D. D. Ho. 1995. Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J. Virol. 69:422-429.
31. Williams, L. M., and M. W. Cloyd. 1991. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 184:723-728.
32. Yamada, O., T. Matsumoto, R. Sasoaka, and T. Kurimura. 1990. Variations in growth capacity of HIV in peripheral blood mononuclear cell preparations from different individuals. AIDS 4:35-40.